Elbow issue ends Sale’s season
BOSTON — Red Sox left-hander Chris Sale is receiving treatment for inflammation in his elbow that will shut him down for the rest of the regular season, another blow to the defending World Series champions whose postseason hopes appear all but dashed.
Orthopedist Dr. James Andrews gave Sale an injection of platelet-rich plasma Monday and said he will be re-evaluated in six weeks.
Looking beyond this frustrating season, the treatment could be good news for the club, which feared Sale might need Tommy John surgery. That would likely have cost him the 2020 season.
The Red Sox were off Monday and entered the day 61⁄2 games out of a wild-card spot.
The 30-year-old Sale was coming off two solid starts in which he combined for 25 strikeouts — including the 2,000th of his career — and allowed only three runs in 142⁄3 innings.
Sale finished the season 6-11 with a 4.40 ERA in 25 starts and 1471⁄3 innings.
Sale, a seven-time All-Star in his 10th season, was the fastest to reach 2,000 strikeouts in major league history.
Last season, Sale dealt with shoulder soreness after the All-Star break, limiting him to 29 innings.
He was also limited in the postseason, but closed out the World Series by striking out then-Dodgers infielder Manny Machado to clinch the Red Sox’s fourth title in 15 seasons.
Sale signed a six-year, $160 million contract in March that includes $50 million in deferred money.
The Red Sox shut down ace Chris Sale, but he won’t need Tommy John surgery.